Skip to main content
. 2016 Oct 4;7(44):71998–72010. doi: 10.18632/oncotarget.12456

Figure 6. Both GF and VC protected against 0.2 mM H2O2-induced inhibition of osteogenic differentiation of BM-MSCs.

Figure 6

ALP activity (A) and calcium contents (B) of the cultures of the four experimental groups normalized to control. (C) Relative mRNAs expressions of Runx2 and Osx in the four experimental groups, quantified by RT-PCR. Data were presented as mean ± SEM. *p < 0.05 and #p < 0.01 vs control, ^p < 0.05 and +p< 0.01 vs H2O2 treatment group.